Weight Regain After Gastric Sleeve: Can Medication, Endoscopy or Revision Surgery Help?

Bariatric specialist discussing treatment options with a patient

Weight regain after gastric sleeve surgery can be frustrating, especially when a patient has worked hard to lose weight and improve their health. However, it does not mean that the original procedure has failed or that there is only one possible solution. Weight recurrence and inadequate weight loss should be assessed carefully in a multidisciplinary bariatric setting.

Depending on the cause, treatment may include anti-obesity medication, an endoscopic revision procedure or revisional bariatric surgery. The most suitable option depends on factors such as eating patterns, medication use, psychological and metabolic health, gastroesophageal reflux, sleeve anatomy, nutritional status and obesity-related conditions.

At Estexper Clinic, patients considering treatment in Turkey should receive an individualized medical assessment before any recommendation is made. No medication, endoscopic procedure or operation is appropriate for every patient, and the available evidence does not establish one universally superior treatment.

Why Can Weight Return After Gastric Sleeve?

Sleeve gastrectomy reduces the size of the stomach and is designed to support long-term weight loss. Over time, however, some patients lose less weight than expected, reach a plateau or regain part of the weight they previously lost. These situations are often described as inadequate weight loss or weight recurrence.

Weight change after surgery can have more than one cause. A thorough evaluation may review:

Changes in portion sizes, grazing, emotional eating or liquid calorie intake
Physical activity and day-to-day lifestyle factors
Medications that may influence appetite or weight
Psychological wellbeing, stress and eating-related difficulties
Metabolic conditions and obesity-related comorbidities
Symptoms of reflux or other gastrointestinal problems
The shape, volume and function of the sleeve
Current nutritional status and adherence to bariatric follow-up

This assessment is important because treatment should address the underlying reason for weight recurrence wherever possible. When evaluation identifies a change in sleeve anatomy, the appropriate approach may differ from one focused mainly on appetite, medication or eating behaviour.

Can Medication Help After Sleeve Gastrectomy?

Anti-obesity medication is often considered the least invasive treatment option. Depending on a patient’s medical history and eligibility, a physician may discuss medicines such as semaglutide or tirzepatide as part of a comprehensive weight-management plan. These medicines are used alongside a reduced-calorie diet and increased physical activity, rather than as a replacement for follow-up care.

FDA-approved semaglutide and tirzepatide products are indicated for chronic weight management in eligible adults. However, evidence specifically involving people who have already undergone sleeve gastrectomy is more limited than evidence from studies of primary obesity treatment. Results from general obesity trials should therefore not be assumed to apply in exactly the same way after bariatric surgery.

What does the research show?

A 2025 retrospective, single-centre study compared revisional endoscopic sleeve gastroplasty with semaglutide and tirzepatide in patients who experienced weight recurrence after sleeve surgery. At 12 months, the endoscopic group had reported total body-weight loss of 13.4%, compared with 9.2% in the combined medication group. Within the medication groups, reported loss was 13.2% with tirzepatide and 8.1% with semaglutide.

These results are informative but should be interpreted cautiously. The study included only 90 treated patients, was not randomised and reported that medication doses were frequently below target. Differences in patient selection, treatment adherence and dosing may have influenced the results. The study does not prove that endoscopy is better than medication for every patient.

Possible advantages and limitations of medication

Medication may be attractive when a patient wishes to avoid another procedure or is not currently a suitable candidate for revision surgery. It can also be considered when sleeve anatomy is not the main concern. The treatment requires medical screening, dose adjustment where appropriate, monitoring for side effects and ongoing lifestyle support. Weight may also require long-term management after the initial treatment period.

A qualified physician must review medical history, current medicines, nutritional status and any contraindications before prescribing. Patients should not obtain or adjust weight-loss medication without appropriate medical supervision.

What Is Endoscopic Revision After a Gastric Sleeve?

An endoscopic revision is performed through the mouth using an endoscope rather than through external abdominal incisions. One option discussed in the research is revisional endoscopic sleeve gastroplasty. The technique uses endoscopic suturing to reduce or reshape parts of the sleeve in selected patients.

Endoscopic treatment may be considered when assessment suggests that sleeve anatomy could be suitable for additional reshaping, while avoiding the greater invasiveness of revision surgery. Suitability depends on the anatomy identified during evaluation, the patient’s symptoms and medical condition, and the expertise available at the treating centre.

Potential benefits

No external abdominal incision is required for the endoscopic approach.
It may provide clinically meaningful additional weight loss in selected patients.
Short-term complication rates may be relatively low compared with revisional surgery, although risks still exist.
It may be an alternative for patients who are not ready for, or are not suitable for, another bariatric operation.

Endoscopic revision is not a guaranteed solution and does not remove the need for dietary, behavioural and medical follow-up. The systematic review and meta-analysis available to date found clinically relevant additional weight loss after endoscopic gastroplasty, re-sleeve and several conversion procedures, but direct comparisons between treatments remain limited.

When Is Revision Bariatric Surgery Considered?

Revision surgery may be considered when weight regain or inadequate weight loss is accompanied by a significant anatomical problem, persistent or recurrent obesity-related disease, or complications such as gastroesophageal reflux. The decision depends on the patient’s symptoms, anatomy, medical history, nutritional status and the potential benefits and risks of each option.

Potential operations after sleeve gastrectomy include:

Conversion to Roux-en-Y gastric bypass
Re-sleeve in selected anatomical situations
Conversion to one-anastomosis gastric bypass
Conversion to single-anastomosis duodenal switch, also called SADI-S, in selected patients

The choice is not based on weight alone. For example, reflux symptoms may influence whether a bypass procedure is more appropriate than reshaping the sleeve. Nutritional status, existing medical conditions, previous weight trajectory and the potential need for a malabsorptive procedure must also be considered.

Benefits and risks of revision surgery

Revision surgery can produce additional weight loss and may offer additional metabolic benefits in carefully selected patients. A 2022 systematic review and meta-analysis suggested that one-anastomosis gastric bypass may be among the more effective options in some settings. However, the available studies were heterogeneous, and the lack of direct comparative trials prevents a firm conclusion that one procedure is best for everyone.

Revisional surgery is technically more complex than primary bariatric surgery. It may carry higher perioperative risk and can involve complications associated with leaks, bleeding, infection, obstruction, nutritional deficiencies or reflux, depending on the procedure and the patient. Operations with a malabsorptive component require careful long-term nutritional monitoring. The surgeon should explain the expected benefits, possible complications and the need for lifelong follow-up before treatment.

Medication, Endoscopy or Surgery: How Are They Compared?

There is no single treatment pathway for all patients with weight regain after gastric sleeve. The options can be compared in general terms, but the final decision must be personalised.

Option	When it may be considered	Important considerations
Anti-obesity medication	When appetite, metabolic factors or weight-management needs are central and the patient is medically eligible	Requires prescription, monitoring, lifestyle support and consideration of long-term treatment
Endoscopic revision	When sleeve anatomy may be suitable for reshaping without another abdominal operation	Evidence is promising but heterogeneous; results depend on patient selection and follow-up
Revision surgery	When reflux, anatomy, comorbidities or inadequate response justify a more definitive surgical approach	Can provide substantial additional treatment but is more complex and carries greater perioperative risk

Current professional guidance supports an individualized strategy that may include medication, endoscopic therapy, re-sleeve or conversion to another bariatric procedure. Decisions should be made by a multidisciplinary team that can assess anatomy, nutrition, medical conditions and psychological factors together.

How Is a Patient Assessed Before Treatment?

Before recommending medication, endoscopy or surgery, the bariatric team should establish what has happened since the original sleeve procedure. The consultation may include a review of the preoperative weight, lowest postoperative weight, current weight and the timing and pattern of any regain.

The evaluation may also involve discussion of eating behaviour, physical activity, reflux symptoms, previous complications, medications and relevant medical conditions. Depending on the situation, the team may assess sleeve anatomy and review laboratory or nutritional information. The exact tests are determined by the physician according to the patient’s symptoms and proposed treatment.

Patients travelling internationally to Turkey should provide previous operative reports, endoscopy or imaging results, medication lists and recent medical records whenever available. A remote preliminary consultation can help organise information, but an in-person examination and appropriate investigations are still required before a final treatment plan.

Recovery and Aftercare

Recovery depends on the chosen treatment. Medication usually involves outpatient monitoring and follow-up visits to assess tolerance, weight change, nutrition and related health conditions. Endoscopic revision and revision surgery have different dietary progression and activity instructions, which must be provided by the treating team.

After any intervention, follow-up is essential. Patients may need nutritional review, behavioural support, monitoring of obesity-related conditions and assessment of reflux or other symptoms. Those undergoing a procedure with a malabsorptive component may require particularly careful long-term monitoring for nutritional deficiencies.

International patients should ask the clinic how follow-up will be arranged after returning home, which records will be provided and whom to contact if symptoms develop. Any plan for treatment in Turkey should include clear communication between the clinic, the patient and the patient’s local healthcare professionals when appropriate.

Frequently Asked Questions

Is weight regain after a gastric sleeve common?

Weight recurrence and inadequate weight loss are recognised issues after metabolic and bariatric surgery, but the available studies use different definitions and follow-up periods. A physician should assess the individual pattern rather than relying on a single weight threshold.

Is revision surgery always better than medication?

No. Surgery may be appropriate for selected patients with reflux, anatomical changes, persistent comorbidities or insufficient response to other options, but it is more invasive and carries greater perioperative risk. Medication may be more suitable for another patient. There is not enough evidence to identify one universally superior treatment.

Can an endoscopic procedure replace revision surgery?

It may be an alternative in selected patients, particularly when sleeve anatomy is suitable and avoiding abdominal surgery is desirable. It is not appropriate for everyone, and the decision requires specialist assessment.

What should I do if I am considering treatment in Turkey?

Choose a qualified bariatric team that can provide multidisciplinary assessment, explain all suitable options and arrange appropriate follow-up. Ask about the proposed procedure, possible risks, nutritional monitoring, emergency support and communication after you return home.

Conclusion

Weight regain after gastric sleeve can sometimes be addressed with medication, revisional endoscopy or conversion surgery. Medication is generally the least invasive option, endoscopic revision may offer meaningful additional weight loss with relatively low short-term complication rates, and revision surgery may provide additional metabolic benefits for carefully selected patients. Each option also has limitations, and current research is based largely on small, retrospective or heterogeneous studies.

The safest approach is a structured evaluation by a qualified multidisciplinary bariatric team. At Estexper Clinic, an individualized assessment can help determine whether the main priorities are medical weight management, sleeve reshaping, treatment of reflux or conversion to another bariatric procedure.